Bayer Announces $10 Billion Roundup Settlement

After months of negotiations, Bayer announced their agreement to compensate thousands of Roundup claims in the United States in an out of court settlement process. There are still many details to be negotiated with Bayer, including individual settlement amounts, but we are pleased to announce that we will be representing our clients in this settlement process.

On June 24, 2020, Bayer announced a series of agreements to compensate tens of thousands of Roundup claims in the United States in an out of court settlement process. According to a company press release, the company hopes to “bring a long period of uncertainty to an end” by agreeing to pay more than $10 billion to those who claimed the herbicide led to the development of non-Hodgkin’s lymphoma.

Are you looking for an update on your Roundup case?

Roundup Settlement Timeline

Bayer agrees to settle at an amount between $8.8 to $9.6 billion with over one hundred thousand claimants. An additional $1.5 billion was also agreed upon to settle future claims.
A cancer patient was awarded $80 million after a jury determined that Roundup was a substantial factor in his diagnosis. A U.S. District Judge later reduced the settlement to $25 million.

A California jury ordered Bayer to pay a couple $2 billion in damages after determining that consumers were not properly informed of the dangers of using Roundup. The settlement was later reduced to $86.7 million by a County judge.
A non-Hodgkin's Lymphoma patient is initially awarded $289 millon ($78 million on appeal) by a San Francisco jury who found that Monsanto failed to inform consumers of the risks involved with the usage of Roundup.
40 plaintiffs filed a lawsuit in the Alameda County Superior Court against Monsanto alleging damages related to certain cancer diagnosis caused by Roundup.
Lawsuits allege that exposure to Roundup may be linked to certain forms of cancer, including non-Hodgkin’s lymphoma, and that Monsanto failed to provide adequate warnings about the alleged risks of cancer associated with the herbicide.
The IARC publishes a reported stating that glyphosate is “probably carcinogenic in humans.”
French court affirms earlier judgment that Monsanto had falsely advertised its herbicide product as “biodegradable” and that it “left the soil clean.”
Monsanto develops “Roundup Ready” seeds.

New York Attorney General files lawsuit against Monsanto based on its false and misleading advertising of Roundup products, leading the company “to cease and desist from publishing or broadcasting any advertisements [in New York] that represent” the toxicity of the product and its impact on the environment.
Roundup brought to market by Monsanto, a multinational agricultural company based in the United States.

Growing Number of Lawsuits Reportedly Pressure Bayer to Settle

In what is expected to be one of the biggest settlements in U.S. history, Bayer has agreed to “make a payment of $8.8 billion to $9.6 billion to resolve the current Roundup litigation,” which includes an amount to cover unresolved claims. An additional $1.25 billion will be set aside to address any potential future claims from those who might develop health complications associated with the use of Roundup herbicide.

According to the New York Times, over two-dozen law firms across the United States have made agreements to settle approximately 95,000 cases while roughly 30,000 claims remain unresolved. A mediator involved in the process believes that many of those claims will eventually agree to the terms of the settlement as well.

Since acquiring Monsanto in 2018, German pharmaceutical and chemical manufacturer Bayer has faced over 125,000 lawsuits in which plaintiffs claimed to have developed non-Hodgkin’s lymphoma after using the popular herbicide Roundup. Mounting lawsuits reportedly put pressure on Bayer to settle, and after considering the potential impact of continued Roundup litigation, the company made the decision to resolve the claims and settle.